Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

Lancet

Volumn 348, Issue 9033, 1996, Pages 981-983

  Jick, Hershel ^a   Derby, Laura E ^a   Myers, Marian Wald ^a   Vasilakis, Catherine ^a   Newton, Katherine M ^b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0030581586     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07114-0     Document Type: Article

References (5)

1. 1 Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-80.
2. 2 Jick H, Watkins RN, Hunter JR, et al. Replacement estrogens and endometrial cancer. N Engl J Med 1979; 300: 218-22.
3. 3 Jick SS, Walker AM, Jick H. Estrogens, progesterone and endometrial cancer. Epidemiology 1993; 4: 20-24.
4. 4 Jick H, Madsen S, Nudelman PM, Perera DR, Stergachis A. Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy 1984; 4: 99-100.
5. 5 Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptive with differing progestagen components. Lancet 1995; 346: 1589-93.